Published in Surg Gynecol Obstet on November 01, 1973
Liver transplantation in a patient with cholangiocarcinoma and ulcerative colitis. Can Med Assoc J (1976) 1.15
Development of a bioartificial liver employing xenogeneic hepatocytes. Cytotechnology (1997) 0.80
Evolution of liver transplantation. Hepatology (1982) 19.54
Orthotopic liver transplantation in ninety-three patients. Surg Gynecol Obstet (1976) 8.11
The use of cyclosporin A and prednisone in cadaver kidney transplantation. Surg Gynecol Obstet (1980) 7.40
The use of heterologous antilymphoid agents in canine renal and liver homotransplantation and in human renal homotransplantation. Surg Gynecol Obstet (1967) 7.24
Fifteen years of clinical liver transplantation. Gastroenterology (1979) 7.19
Involvement of topoisomerase IV and DNA gyrase as ciprofloxacin targets in Streptococcus pneumoniae. Antimicrob Agents Chemother (1996) 7.10
Liver transplantation with use of cyclosporin a and prednisone. N Engl J Med (1981) 6.95
Orthotopic homotransplantation of the human liver. Ann Surg (1968) 6.64
Cloning and characterization of a DNA gyrase A gene from Escherichia coli that confers clinical resistance to 4-quinolones. Antimicrob Agents Chemother (1989) 5.80
Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy. Lancet (1984) 5.74
Progress in and deterrents to orthotopic liver transplantation, with special reference to survival, resistance to hyperacute rejection, and biliary duct reconstruction. Transplant Proc (1974) 5.53
Extended survival in 3 cases of orthotopic homotransplantation of the human liver. Surgery (1968) 5.44
Cyclophosphamide and whole organ transplantation in human beings. Surg Gynecol Obstet (1971) 5.24
DNA gyrase gyrA mutations in ciprofloxacin-resistant strains of Staphylococcus aureus: close similarity with quinolone resistance mutations in Escherichia coli. J Bacteriol (1990) 5.13
4-Quinolone resistance mutations in the DNA gyrase of Escherichia coli clinical isolates identified by using the polymerase chain reaction. Antimicrob Agents Chemother (1991) 4.35
Cloning and characterization of the parC and parE genes of Streptococcus pneumoniae encoding DNA topoisomerase IV: role in fluoroquinolone resistance. J Bacteriol (1996) 4.34
DNA gyrase: purification and catalytic properties of a fragment of gyrase B protein. Proc Natl Acad Sci U S A (1979) 4.34
Biliary complications after liver transplantation: with special reference to the biliary cast syndrome and techniques of secondary duct repair. Surgery (1977) 4.08
Nucleotide sequence of the Staphylococcus aureus gyrB-gyrA locus encoding the DNA gyrase A and B proteins. J Bacteriol (1992) 3.95
DNA gyrase action involves the introduction of transient double-strand breaks into DNA. Proc Natl Acad Sci U S A (1980) 3.87
The preparation and testing of horse antidog and antihuman antilymphoid plasma or serum and its protein fractions. Surg Gynecol Obstet (1967) 3.86
The origin, hormonal nature, and action of hepatotrophic substances in portal venous blood. Surg Gynecol Obstet (1973) 3.84
Targeting of DNA gyrase in Streptococcus pneumoniae by sparfloxacin: selective targeting of gyrase or topoisomerase IV by quinolones. Antimicrob Agents Chemother (1997) 3.83
Effects of insulin, glucagon, and insuling/glucagon infusions on liver morphology and cell division after complete portacaval shunt in dogs. Lancet (1976) 3.74
Transplantation of multiple abdominal viscera. JAMA (1989) 3.59
Canine liver transplantation under Nva2-cyclosporine versus cyclosporine. Transplantation (1986) 3.54
Cadaveric renal transplantation. An analysis of 65 cases. Lancet (1969) 3.48
Selected topics on FK 506, with special references to rescue of extrahepatic whole organ grafts, transplantation of "forbidden organs," side effects, mechanisms, and practical pharmacokinetics. Transplant Proc (1991) 3.40
Use of OKT3 with cyclosporin and steroids for reversal of acute kidney and liver allograft rejection. Nephron (1987) 3.26
Delayed biliary duct obstruction after orthotopic liver transplantation. Surgery (1972) 3.26
DNA gyrase and topoisomerase IV are dual targets of clinafloxacin action in Streptococcus pneumoniae. Antimicrob Agents Chemother (1998) 3.12
Chronic survival after human renal homotransplantation. Lymphocyte-antigen matching, pathology and influence of thymectomy. Ann Surg (1965) 3.00
DNA cloning and organization of the Staphylococcus aureus gyrA and gyrB genes: close homology among gyrase proteins and implications for 4-quinolone action and resistance. J Bacteriol (1990) 2.96
Cyclosporin A and steroid therapy in sixty-six cadaver kidney recipients. Surg Gynecol Obstet (1981) 2.92
Ciprofloxacin resistance in coagulase-positive and -negative staphylococci: role of mutations at serine 84 in the DNA gyrase A protein of Staphylococcus aureus and Staphylococcus epidermidis. Antimicrob Agents Chemother (1991) 2.80
Studies of homograft sex and of gamma globulin phenotypes after orthotopic homotransplantation of the human liver. Surg Forum (1969) 2.80
Site-specific interaction of DNA gyrase with DNA. Proc Natl Acad Sci U S A (1981) 2.75
Growth-stimulating factor in regenerating canine liver. Lancet (1979) 2.61
Studies of blood flow and ultrastructural changes in rejecting and nonrejecting canine orthotopic liver homografts. Surgery (1968) 2.58
Detection of circulating immune complexes in pathological human sera. Lancet (1975) 2.51
Liver transplantation, 1980, with particular reference to cyclosporin-A. Transplant Proc (1981) 2.49
Acute neurological complications after liver transplantation with particular reference to intraoperative cerebral air embolus. Ann Surg (1978) 2.48
Portal diversion for the treatment of glycogen storage disease in humans. Ann Surg (1973) 2.44
Hepatotrophic effects of FK506 in dogs. Transplantation (1991) 2.39
The Eck fistula in animals and humans. Curr Probl Surg (1983) 2.35
Cloning and sequence analysis of the rat augmenter of liver regeneration (ALR) gene: expression of biologically active recombinant ALR and demonstration of tissue distribution. Proc Natl Acad Sci U S A (1994) 2.35
Portacaval shunt in patients with familial hypercholesterolemia. Ann Surg (1983) 2.33
The hepatotropic influence of cyclosporine. Surgery (1990) 2.27
SEROTYPING FOR HOMOTRANSPLANTATION. VII. SELECTION OF KIDNEY DONORS FOR THIRTY-TWO RECIPIENTS. Ann N Y Acad Sci (1966) 2.25
Human cadaveric renal transplantation. Report of twenty cases. Br Med J (1965) 2.12
Human renal transplants. I. Glomerular changes. Lab Invest (1967) 2.06
Augmentation of rat liver regeneration by FK 506 compared with cyclosporin. Lancet (1989) 2.01
Interaction of bleomycin A2 with deoxyribonucleic acid: DNA unwinding and inhibition of bleomycin-induced DNA breakage by cationic thiazole amides related to bleomycin A2. Biochemistry (1985) 1.94
DNase I hypersensitive sites in the chromatin of human mu immunoglobulin heavy-chain genes. Nature (1984) 1.94
Infections in recipients of liver homografts. N Engl J Med (1968) 1.92
The influence of portal blood upon lipid metabolism in normal and diabetic dogs and baboons. Surg Gynecol Obstet (1975) 1.91
Functional imprinting and epigenetic modification of the human SNRPN gene. Hum Mol Genet (1993) 1.84
Progress in homotransplantation of the liver. Adv Surg (1966) 1.83
Fungus infections after liver transplantation. Ann Surg (1977) 1.81
Liver allograft. Its use in chronic active hepatitis with macronodular cirrhosis, hepatitis B surface antigen. Arch Surg (1979) 1.80
Platelet changes following clinical and experimental hepatic homotransplantation. Arch Surg (1968) 1.78
Serotyping for homotransplantation. V. Evaluation of a matching scheme. Transplantation (1966) 1.78
The quality of life after liver transplantation. Transplant Proc (1979) 1.78
Liver regeneration in dogs: morphologic and chemical changes. J Surg Res (1978) 1.78
Prognostic factors in sterile pancreatic necrosis. Gastroenterology (1992) 1.77
Portal hepatotrophic factors, diabetes mellitus and acute liver atrophy, hypertrophy and regeneration. Surg Gynecol Obstet (1975) 1.74
Streptococcus pneumoniae DNA gyrase and topoisomerase IV: overexpression, purification, and differential inhibition by fluoroquinolones. Antimicrob Agents Chemother (1999) 1.73
Organ distribution in rats of two members of the low-density lipoprotein receptor gene family, gp330 and LRP/alpha 2MR, and the receptor-associated protein (RAP). J Histochem Cytochem (1994) 1.72
Stimulation of hepatic regeneration after partial hepatectomy by infusion of a cytosol extract from regenerating dog liver. Surg Gynecol Obstet (1980) 1.72
Homotransplantation of the liver. Transplantation (1967) 1.71
Augmenter of liver regeneration: its place in the universe of hepatic growth factors. Hepatology (1994) 1.70
Human renal transplants. II. Immunofluorescent and immunoferritin studies. Lab Invest (1968) 1.69
Auxiliary liver transplantation: effect of host portacaval shunt. Experimental and clinical observations. Arch Surg (1966) 1.66
Portacaval shunt in hyperlipoproteinaemia. Lancet (1973) 1.66
The effect of splanchnic viscera removal upon canine liver regeneration. Surg Gynecol Obstet (1978) 1.63
Intraportal insulin protects from the liver injury of portacaval shunt in dogs. Lancet (1975) 1.55
The effect of partial portacaval transposition on the canine liver. Surgery (1967) 1.54
Renal homotransplantation with venous outflow or infusion of antigen into the portal vein of dogs or pigs. Transplantation at portal site. Transplantation (1977) 1.54
gyrA mutations in ciprofloxacin-resistant, methicillin-resistant Staphylococcus aureus from Indiana, Minnesota, and Tennessee. J Infect Dis (1991) 1.54
Liver replacement for alpha1-antitrypsin deficiency. Surgery (1977) 1.53
Effects of long-chain triglyceride emulsions on reticuloendothelial system function in humans. JPEN J Parenter Enteral Nutr (1990) 1.53
Antibody-induced redistribution of Heymann antigen on the surface of cultured glomerular visceral epithelial cells: possible role in the pathogenesis of Heymann glomerulonephritis. J Immunol (1985) 1.52
DNA gyrase complex with DNA: determinants for site-specific DNA breakage. EMBO J (1986) 1.52
Liver replacement for pediatric patients. Pediatrics (1979) 1.51
Clinical and pathologic observations after orthotopic transplantation of the human liver. Surg Gynecol Obstet (1969) 1.51
Infections complicating orthotopic liver transplantation: a study emphasizing graft-related septicemia. Arch Surg (1976) 1.50
Effect of lacto-N-neotetraose, asialoganglioside-GM1 and neuraminidase on adherence of otitis media-associated serotypes of Streptococcus pneumoniae to chinchilla tracheal epithelium. Microb Pathog (1999) 1.46
Potent antipneumococcal activity of gemifloxacin is associated with dual targeting of gyrase and topoisomerase IV, an in vivo target preference for gyrase, and enhanced stabilization of cleavable complexes in vitro. Antimicrob Agents Chemother (2000) 1.45
Decline in survival after liver transplantation. Arch Surg (1980) 1.39
Autopsy findings in a long-surviving liver recipient. N Engl J Med (1973) 1.36
Pathology of liver transplantation. Transplant Rev (1969) 1.36
DNA supercoiling and gene expression. Nature (1984) 1.35
The specific influence of nonhepatic splanchnic venous blood flow on the liver. Surg Forum (1965) 1.34
The effect of diabetes mellitus on portal blood hepatotrophic factors in dogs. Surg Gynecol Obstet (1975) 1.33
Virus-induced obstruction of the ureteric and cystic duct in allograft recipients. Transplant Proc (1973) 1.33
Human renal transplants. 3. Immunopathologic studies. Lab Invest (1970) 1.31
Current policies in hepatic transplantation: candidacy of patients with alcoholic liver disease or preformed antidonor antibodies and a reappraisal of biliary duct reconstruction. Ann N Y Acad Sci (1975) 1.30
Quinolone resistance mutations in Streptococcus pneumoniae GyrA and ParC proteins: mechanistic insights into quinolone action from enzymatic analysis, intracellular levels, and phenotypes of wild-type and mutant proteins. Antimicrob Agents Chemother (2001) 1.27